BR9710566A - M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio - Google Patents

M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio

Info

Publication number
BR9710566A
BR9710566A BR9710566A BR9710566A BR9710566A BR 9710566 A BR9710566 A BR 9710566A BR 9710566 A BR9710566 A BR 9710566A BR 9710566 A BR9710566 A BR 9710566A BR 9710566 A BR9710566 A BR 9710566A
Authority
BR
Brazil
Prior art keywords
progestin
estrogen
combination
monophysical
kit
Prior art date
Application number
BR9710566A
Other languages
English (en)
Inventor
Michael Jay Gast
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24757773&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9710566(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9710566A publication Critical patent/BR9710566A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
BR9710566A 1996-07-26 1997-07-23 M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio BR9710566A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68679096A 1996-07-26 1996-07-26
PCT/US1997/012795 WO1998004269A1 (en) 1996-07-26 1997-07-23 Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen

Publications (1)

Publication Number Publication Date
BR9710566A true BR9710566A (pt) 1999-08-17

Family

ID=24757773

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710566A BR9710566A (pt) 1996-07-26 1997-07-23 M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio

Country Status (16)

Country Link
EP (1) EP0956024B1 (pt)
JP (1) JP2000515890A (pt)
KR (1) KR100518102B1 (pt)
CN (1) CN1186024C (pt)
AT (1) ATE271386T1 (pt)
AU (1) AU726091B2 (pt)
BR (1) BR9710566A (pt)
CA (1) CA2261689A1 (pt)
DE (1) DE69729956T2 (pt)
ES (1) ES2223081T3 (pt)
HK (1) HK1022843A1 (pt)
HU (1) HUP9904344A3 (pt)
IL (1) IL127797A (pt)
NZ (1) NZ333750A (pt)
PT (1) PT956024E (pt)
WO (1) WO1998004269A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP2305267A3 (en) * 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
EE05317B1 (et) * 1999-08-31 2010-08-16 Bayer Schering Pharma Aktiengesellschaft Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina
IL148339A0 (en) * 1999-08-31 2002-09-12 Schering Ag Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
SK288129B6 (sk) * 2000-01-18 2013-10-02 Bayer Schering Pharma Aktiengesellschaft Drospirenone for hormonal substitution treatment
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
BRPI0116793B8 (pt) * 2000-12-14 2021-05-25 Johnson & Johnson produtos de hormônio de esteróide e métodos para prepará-los
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
DE602004018921D1 (de) * 2003-06-25 2009-02-26 Bayer Schering Pharma Ag D dienogest
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
AU2011226911B2 (en) * 2004-04-30 2014-06-19 Bayer Intellectual Property Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
US20060009428A1 (en) 2004-07-07 2006-01-12 Wyeth Cyclic progestin regimens and kits
EP1690529A1 (de) * 2005-02-15 2006-08-16 Schering AG Feste perorale Arzneiform zur Kontrazeption, die Dienogest und Ethinylestradiol enthält
EP1690543A1 (de) * 2005-02-15 2006-08-16 Schering AG Pharmazeutisches Präparat zur Kontrazeption
AU2006215822B2 (en) * 2005-02-15 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Solid peroral contraceptive drug
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
DE102008040908A1 (de) 2008-07-31 2010-02-11 Deere & Company, Moline Kühleranordnung für ein Fahrzeugkühlsystem
EP2324832B2 (de) * 2009-11-09 2016-11-30 Biogena Naturprodukte GmbH & Co KG Nahrungsergänzungsmittel bei Einnahme von hormonellen Kontrazeptiva

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption

Also Published As

Publication number Publication date
CN1226168A (zh) 1999-08-18
CA2261689A1 (en) 1998-02-05
KR100518102B1 (ko) 2005-10-04
ES2223081T3 (es) 2005-02-16
JP2000515890A (ja) 2000-11-28
KR20000029515A (ko) 2000-05-25
HUP9904344A2 (hu) 2000-05-28
CN1186024C (zh) 2005-01-26
PT956024E (pt) 2004-10-29
IL127797A0 (en) 1999-10-28
EP0956024B1 (en) 2004-07-21
HUP9904344A3 (en) 2001-03-28
HK1022843A1 (en) 2000-08-25
IL127797A (en) 2004-08-31
NZ333750A (en) 2000-09-29
WO1998004269A1 (en) 1998-02-05
DE69729956T2 (de) 2004-12-16
AU726091B2 (en) 2000-11-02
AU3888797A (en) 1998-02-20
ATE271386T1 (de) 2004-08-15
EP0956024A1 (en) 1999-11-17
DE69729956D1 (de) 2004-08-26

Similar Documents

Publication Publication Date Title
BR9710566A (pt) M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio
CY1105276T1 (el) Τριφασικο στοματικο αντισυλληπτικο
AU645637B2 (en) Contraceptive regimen
DK0491415T3 (da) Orale svangerskabsforebyggende midler med lavt østrogen
DK365887D0 (da) Kombinationsdoseringsform til hormonbehandling af kvinder i prae-menopausen
WO1998004246A3 (en) Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
DK0917466T3 (da) Oralt antikonceptionsmiddel
PT921804E (pt) Metodo contraceptivo bifasico e conjunto ("kit") compreendendo uma combinacao de uma progestina e um estrogenio

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B25D Requested change of name of applicant approved
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO DE ACORDO COM O ARTS. 8O E 15O DA LPI.